Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TIPARP-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SIGLEC7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A7-CYP3A51P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GSG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHBP1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYT15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TM6SF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC102723620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3C2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM162B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF10C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF32-AS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on